Nanalysis Scientific Corp.
NSCIF
$0.09
$0.00-3.71%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.16% | 13.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.16% | 13.60% | |||
| Cost of Revenue | 6.52% | 5.96% | |||
| Gross Profit | -16.93% | 40.92% | |||
| SG&A Expenses | 9.49% | -13.07% | |||
| Depreciation & Amortization | 65.42% | -39.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.64% | -2.08% | |||
| Operating Income | -381.14% | 126.30% | |||
| Income Before Tax | -67.12% | 50.40% | |||
| Income Tax Expenses | 343.48% | -199.14% | |||
| Earnings from Continuing Operations | -76.17% | 51.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -76.17% | 51.99% | |||
| EBIT | -381.14% | 126.30% | |||
| EBITDA | -256.88% | 144.16% | |||
| EPS Basic | -48.89% | 52.63% | |||
| Normalized Basic EPS | -41.38% | 48.21% | |||
| EPS Diluted | 0.00% | 24.21% | |||
| Normalized Diluted EPS | -41.38% | 48.21% | |||
| Average Basic Shares Outstanding | 16.77% | 2.09% | |||
| Average Diluted Shares Outstanding | 16.77% | 2.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||